Meeting Banner
Abstract #1923

Investigation of the biophysical basis of relaxivity contrast imaging as a biomarker for myofiber microstructural changes in an ALS model

Natenael B Semmineh1, Ethan Mathew2, Bruce Damon3, and C Chad Quarles1
1Cancer Systems Imaging, The university of Texas MD Anderson Cancer Center, Houston, TX, United States, 2Barrow Neuroimaging Innovation Center, Barrow Neurological Institute, Phoenix, TX, United States, 3Carle Clinical Imaging Research Program Stephens Family Clinical Research Institute Carle Health, Urbana, IL, United States

Synopsis

Keywords: Neurodegeneration, Microstructure, amyotrophic lateral sclerosis - ALSAmyotrophic lateral sclerosis (ALS) is a fatal upper and lower motor neuron degradation disease that leads to progressive myofiber abnormalities (e.g., decreased size and distribution). The relaxivity contrast imaging (RCI) parameter, TRATE (tissue transverse relaxivity at tracer equilibrium), has been shown to decrease during ALS induced myofiber degradation. The goal of this study is to expand a validated computational method to investigate the biophysical basis of TRATE in muscles of ALS patients and to optimize RCI acquisition parameters.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords